{"description":"1/9 participants did not receive any therapy.","eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":2,"description":"Phase 1, Arm 1, Dose Escalation, ORIGINAL Dose Level 1: Participants received Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Sunday, Monday, Tuesday (SuMT) q week with Pembrolizumab infusion q3weeks","id":"EG000","otherNumAffected":2,"otherNumAtRisk":2,"seriousNumAffected":2,"seriousNumAtRisk":2,"title":"Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Sunday, Monday, Tuesday (SuMT)"},{"deathsNumAffected":0,"deathsNumAtRisk":2,"description":"Phase 1, Arm 1, Dose Escalation, ORIGINAL Dose Level -1: Participants received Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Monday-Tuesday (MT) q week. Participants received Pembrolizumab infusion q3weeks.","id":"EG001","otherNumAffected":2,"otherNumAtRisk":2,"seriousNumAffected":1,"seriousNumAtRisk":2,"title":"Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Monday-Tuesday (MT)"},{"deathsNumAffected":0,"deathsNumAtRisk":4,"description":"Phase 1, Arm 1, Dose Escalation, Revised Dose Level 1. Participants received Decitabine 0.21 mg/kg + Tetrahydrouridine 10mg/kg TW weekly x 2 weeks q 3 weeks. Participants received pembrolizumab infusion q 3weeks.","id":"EG002","otherNumAffected":4,"otherNumAtRisk":4,"seriousNumAffected":2,"seriousNumAtRisk":4,"title":"Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks"},{"deathsNumAffected":0,"deathsNumAtRisk":0,"description":"Phase 1, Arm 1, Dose Escalation, Revised Dose Level -1. Participants received Decitabine 0.17 mg/kg + Tetrahydrouridine 10mg/kg TW weekly x 2 weeks q 3 weeks. Participants received pembrolizumab infusion q 3weeks.","id":"EG003","otherNumAffected":0,"otherNumAtRisk":0,"seriousNumAffected":0,"seriousNumAtRisk":0,"title":"Decitabine 0.17mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks"}],"frequencyThreshold":"0","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":4,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Activated partial thromboplastin time prolonged"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":4,"numEvents":4},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Alkaline phosphatase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2,"numEvents":7},{"groupId":"EG001","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":4,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Anemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":2,"numEvents":2},{"groupId":"EG002","numAffected":0,"numAtRisk":4,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Blood bilirubin increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":4,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Blurred vision"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":4,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Bronchopulmonary hemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":4,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Colitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":2,"numEvents":2},{"groupId":"EG002","numAffected":0,"numAtRisk":4,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Creatinine increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":4,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Diarrhea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":4,"numEvents":2},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":4,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Hyperkalemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2,"numEvents":2},{"groupId":"EG001","numAffected":2,"numAtRisk":2,"numEvents":2},{"groupId":"EG002","numAffected":1,"numAtRisk":4,"numEvents":2},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Hypoalbuminemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":4,"numEvents":2},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Lipase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2,"numEvents":16},{"groupId":"EG001","numAffected":2,"numAtRisk":2,"numEvents":23},{"groupId":"EG002","numAffected":1,"numAtRisk":4,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Lymphocyte count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2,"numEvents":9},{"groupId":"EG001","numAffected":2,"numAtRisk":2,"numEvents":4},{"groupId":"EG002","numAffected":1,"numAtRisk":4,"numEvents":11},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Neutrophil count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":4,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":4,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Pain in extremity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":4,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Postnasal drip"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":4,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Proteinuria"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":4,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":4,"numEvents":5},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Serum amylase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":4,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Skin ulceration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":4,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Soft tissue infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":4,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Upper respiratory infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":4,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Urinary incontinence"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2,"numEvents":6},{"groupId":"EG001","numAffected":2,"numAtRisk":2,"numEvents":5},{"groupId":"EG002","numAffected":1,"numAtRisk":4,"numEvents":12},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"White blood cell decreased"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":4,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":4,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Hyponatremia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2,"numEvents":5},{"groupId":"EG001","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":4,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Lymphocyte count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2,"numEvents":3},{"groupId":"EG001","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG002","numAffected":1,"numAtRisk":4,"numEvents":5},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Neutrophil count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG002","numAffected":1,"numAtRisk":4,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":2,"numEvents":2},{"groupId":"EG002","numAffected":0,"numAtRisk":4,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"Skin infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"CTCAE (5.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2,"numEvents":3},{"groupId":"EG001","numAffected":1,"numAtRisk":2,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":4,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":0,"numEvents":0}],"term":"White blood cell decreased"}],"timeFrame":"Date treatment consent signed to date off study, approximately 2 months/10 days, 10 months/29 days, 20 months/30 days for the first, second and third group respectively."}